nano-materials-2018-scientifictracks

Page 11

Notes:

allied

academies

Journal of Materials Science and Nanotechnology | Volume 2

October 29-30, 2018 | London, UK

Nanomaterials and Nanotechnology

International Conference on

Two decades of commercializing nanotechnology for medical devices: Real products helping real

humans

Thomas J Webster

Northeastern University, USA

here is an acute shortage of organs due to disease, trauma,

congenital defect and most importantly, age related

maladies. While tissue engineering (and nanotechnology) has

made great strides towards improving tissue growth, infection

control has been largely forgotten. Critically, as a consequence,

the Centers for Disease Control have predicted more deaths

from antibiotic-resistant bacteria than all cancers combined

by 2050. Moreover, there has been a lack of translation to

real commercial products. This talk will summarize how

nanotechnology can be used to increase tissue growth and

decrease implant infection without using antibiotics (while

getting regulatory approval). Our group has shown that same

nanofeatures, Nano-modifications, and nanoparticles can

reduce bacterial growth without using antibiotics. This talk

will summarize techniques and efforts to create nanofeatures

for a wide range of medical devices and tissue engineering

applications, particularly those that have received FDA

approval and are currently being implanted in humans.

Speaker Biography

Thomas J Webster joined the chemical engineering department in fall 2012. The

primary focus of our research is the design, synthesis and evaluation of nanomaterials

for various medical applications. This includes self-assembled chemistries,

nanoparticles, nanotubes and nanostructured surfaces. Medical applications include

inhibiting bacteria growth, inflammation and promoting tissue growth. Tissues of

particular interest are bone, cartilage, skin, nervous system, bladder, cardiovascular

and vascular. There is also an interest in anti-cancer applications where nanomaterials

can be used to decrease cancer cell functions without the use of pharmaceutical

agents. There is also a large interest in developing

in situ

sensors which can sense

biological responses to medical devices and respond in real time to ensure implant

success. Lastly, there is an interest in understanding the environmental and human

health toxicity of nanomaterials.